Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study

BACKGROUND: A new descriptive classification scheme for biomarkers used in Alzheimer's and cognitive aging research, labeled ATN, was recently proposed. One implementation of this ATN construct dichotomizes biomarkers of amyloid, tau, and neurodegeneration/neuronal injury as normal or abnormal...

Descripción completa

Detalles Bibliográficos
Autores principales: Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Therneau, Terry M., Knopman, David S., Lowe, Val, Vemuri, Prashanthi, Mielke, Michelle M., Roberts, Rosebud O., Machulda, Mary M., Senjem, Matthew L., Gunter, Jeffrey L., Rocca, Walter A., Petersen, Ronald C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516534/
https://www.ncbi.nlm.nih.gov/pubmed/28456479
http://dx.doi.org/10.1016/S1474-4422(17)30077-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516534/
https://www.ncbi.nlm.nih.gov/pubmed/28456479
http://dx.doi.org/10.1016/S1474-4422(17)30077-7

Ejemplares similares